Tax withholding on RSU vesting for Amphastar (AMPH) CFO Peters
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amphastar Pharmaceuticals CFO William J. Peters reported a routine tax-related share disposition. On the vesting of restricted stock units, 1,973 shares of common stock were withheld at $18.18 per share to satisfy his tax liability, rather than sold on the open market.
After this withholding, Peters directly holds 175,063 shares of Amphastar common stock. This filing reflects a compensation-driven, non-discretionary tax-withholding event, not an open-market purchase or sale decision.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
PETERS WILLIAM J
Role
CFO, EVP & TREASURER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,973 | $18.18 | $36K |
Holdings After Transaction:
Common Stock — 175,063 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Amphastar (AMPH) report for CFO William J. Peters?
Amphastar’s CFO William J. Peters reported shares withheld for taxes, not an open-market trade. 1,973 common shares were retained by the company to cover tax obligations when his restricted stock units vested.
Was the Amphastar (AMPH) CFO’s Form 4 transaction a stock sale?
The CFO’s Form 4 transaction was a tax-withholding disposition, not an open-market sale. Shares were withheld by Amphastar to pay taxes when restricted stock units vested, a standard compensation-related event.